1
项与 Acolbifene Hydrochloride/Prasterone 相关的临床试验DHEA + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women (Placebo Controlled, Double Blind and Randomized Phase III Study to Evaluate the Effects of 12-Week Treatment With DHEA (Prasterone) and Acolbifene on Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women)
The purpose of this Phase III trial is to evaluate the efficacy of oral administration of dehydroepiandrosterone (DHEA) combined with acolbifene (a selective estrogen receptor modulator (SERM)) on vasomotor symptoms (hot flushes) in postmenopausal women.
100 项与 Acolbifene Hydrochloride/Prasterone 相关的临床结果
100 项与 Acolbifene Hydrochloride/Prasterone 相关的转化医学
100 项与 Acolbifene Hydrochloride/Prasterone 相关的专利(医药)
100 项与 Acolbifene Hydrochloride/Prasterone 相关的药物交易